Section |
Status |
CCG |
Name |
10.01.03 |
Formulary
|
 |
Abatacept injection |
01.05.03 |
Formulary
|
 |
Adalimumab injection IBD |
10.01.03 |
Formulary
|
 |
Adalimumab injection rheumatology indications |
02.12 |
Restricted Use
|
 |
Alirocumab injection |
01.02 |
Restricted Use
|
 |
Aprepitant caps, oral suspension gastroparesis - off-label |
09.01.04 |
Formulary
|
 |
Avatrombopag tabs |
10.01.03 |
Formulary
|
 |
Baricitinib tabs |
01.02 |
Formulary
|
 |
Botulinum toxin A Xeomin® - chronic sialorrhoea |
01.02 |
Restricted Use
|
 |
Botulinum toxin A Xeomin® - gastroenterology endoscopic indications off-label |
01.07.04 |
Restricted Use
|
 |
Botulinum toxin A Xeomin® - anal-fissures - off-label |
12.04 |
Restricted Use
|
 |
Botulinum toxin type A Xeomin® - Spasmodic dysphonia - off-label |
10.01.03 |
Formulary
|
 |
Certolizumab pegol injection musculoskeletal conditions |
09.05.01.02 |
Restricted Use
|
 |
Cinacalcet tablets secondary hyperparathyroidism in ESRD |
05.01.07 |
Formulary
|
 |
Colistimethate sodium powder for solution for injection or inhalation - Colomycin® brand Pseudomonas lung infection in non-CF bronchiectasis - off-label |
02.01.01 |
Formulary
|
 |
Digoxin specific antibody fragments |
09.01.04 |
Restricted Use
|
 |
Eltrombopag tablets |
09.01.04 |
Restricted Use
|
 |
Eltrombopag tablets |
10.01.03 |
Formulary
|
 |
Etanercept injection rheumatology indications |
02.12 |
Restricted Use
|
 |
Evolocumab injection |
04.07.04.02 |
Formulary
|
 |
Fremanezumab subcutaneous injection |
04.07.04.02 |
Formulary
|
 |
Galcanezumab subcutaneous injection |
01.05.03 |
Formulary
|
 |
Golimumab injection ulcerative colitis |
10.01.03 |
Formulary
|
 |
Golimumab injection rheumatology indications |
02.11 |
Formulary
|
 |
Idarucizumab infusion |
01.05.03 |
Formulary
|
 |
Infliximab injection cancer immunotherapy related colitis - off-label |
01.05.03 |
Formulary
|
 |
Infliximab injection IBD |
10.01.03 |
Formulary
|
 |
Infliximab injection licensed rheumatology indications |
09.01.04 |
Formulary
|
 |
Lusutrombopag tabs |
08.03.04.03 |
Formulary
|
 |
Octreotide injection off-label uses |
08.02.03 |
Restricted Use
|
 |
Rituximab injection TTP - off-label |
09.01.04 |
Formulary
|
 |
Rituximab injection immune thrombocytopenia - off-label |
10.01.03 |
Formulary
|
 |
Rituximab injection rheumatology - licensed indications |
09.01.04 |
Restricted Use
|
 |
Romiplostim injection |
10.01.03 |
Formulary
|
 |
Sarilumab pre-filled pen or syringe |
10.01.03 |
Formulary
|
 |
Secukinumab injection ankylosing spondylitis & psoriatic arthritis |
06.06.01 |
Formulary
|
 |
Teriparatide injection use in women |
10.01.03 |
Formulary
|
 |
Tocilizumab injection arthritis |
01.05.03 |
Formulary
|
 |
Tofacitinib tabs gastroenterology indications |
10.01.03 |
Formulary
|
 |
Tofacitinib tabs rheumatology indications |
10.01.03 |
Formulary
|
 |
Upadacitinib prolonged release tablets |
01.05.03 |
Formulary
|
 |
Ustekinumab injection gastrointestinal indications |
10.01.03 |
Formulary
|
 |
Ustekinumab injection psoriatic arthritis |
01.05.03 |
Formulary
|
 |
Vedolizumab injection |